Benzothiazinone analogs as Anti-Mycobacterium tuberculosis DprE1 irreversible inhibitors: Covalent docking, validation, and molecular dynamics simulations.
Mycobacterium tuberculosis is a lethal human pathogen, with the key flavoenzyme for catalyzing bacterial cell-wall biosynthesis, decaprenylphosphoryl-D-ribose oxidase (DprE1), considered an Achilles heal for tuberculosis (TB) progression. Inhibition of DprE1 blocks cell wall biosynthesis and is a hi...
Saved in:
| Main Authors: | Mahmoud A A Ibrahim, Doaa G M Mahmoud, Alaa H M Abdelrahman, Khlood A A Abdeljawaad, Gamal A H Mekhemer, Tamer Shoeib, Mohamed A El-Tayeb, Peter A Sidhom, Paul W Paré, Mohamed-Elamir F Hegazy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0314422&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical trial of DprE1 inhibitors: from bench to bedside
by: A. V. Snehalatha, et al.
Published: (2025-05-01) -
DprE1 inhibitors – a prospective target for development of antituberculosis drugs
by: A. V. Kukurika
Published: (2022-06-01) -
Bibliometric and Visualization Analysis of DprE1 Inhibitors to Combat Tuberculosis
by: Wang Q, et al.
Published: (2025-04-01) -
A Computational Approach to Repurposing Natural Products for DprE1 Inhibition
by: A. V. Snehalatha, et al.
Published: (2025-01-01) -
In-silico design and evaluation of quinoline-dione derivatives as Mycobacterium tuberculosis DprE1 inhibitors
by: Maimuna Shehu Rufa’i, et al.
Published: (2025-08-01)